|
Facebook
Twitter
Linkedin
|
MPO Predicts Death Risk With Coronary Angiography
Cardiology
Go to group page
Wednesday, 10 March 2010
Myeloperoxidase (MPO) predicts the risk of cardiovascular mortality in patients who undergo coronary angiography, according to research published in the Journal of the American College of Cardiology. Read More








